Hypertension reduction by device-guided breathing has a dose-response relationship
نویسندگان
چکیده
منابع مشابه
Reduction of sympathetic nervous activity with device-guided breathing.
To the Editor: Hypertension is a chronic disease that affects about 25% of the population around the world. Treatment by pharmacologic intervention is effective but has side effects and significant costs. Techniques that reduce respiratory rate have been shown to be an effective nonpharmacologic treatment in controlling blood pressure (BP). Evidence has shown that a slow and deep breathing rate...
متن کاملDevice - assisted Slow Breathing as a Complementary Treatment for Hypertension
By Robert P. Nolan Guidelines for primary and secondary prevention of cardiovascular disease in Europe and North America suggest that behavioral interventions (relaxation training, stress management, biofeedback or meditation) may assist the treatment of patients for whom psychosocial stress is of clinical concern. Several reviews have evaluated whether these behavioral interventions can be uti...
متن کاملSuccessful efavirenz dose reduction guided by therapeutic drug monitoring.
BACKGROUND There are potential benefits to individualizing dosage in patients treated with efavirenz (EFV). We tested a simplified algorithm based on a Bayesian pharmacokinetic approach for guiding dose reduction in patients with EFV concentrations above the 75th percentile (P75) with documented virological efficacy. METHODS We designed a prospective, open-label, multicentre study. All consen...
متن کاملEfficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient data.
IMPORTANCE Device-guided breathing (DGB) is recommended by the American Heart Association for its blood pressure-lowering effects. Most previous studies that showed beneficial effects on blood pressure had low methodological quality and only investigated short-term blood pressure effects. OBJECTIVE To assess the efficacy of DGB on blood pressure in a meta-analysis of individual patient data f...
متن کاملPropranolol in hypertension: a dose-response study.
The effect of propranolol was studied in a double-blind crossover trial in 24 carefully selected hypertensive outpatients. Each patient received propranolol 60 mg/day, 120 mg/day, 240 mg/day, and placebo for four weeks each according to a randomised sequence. Propranolol 60 mg/day was no better than placebo in reducing blood pressure. The effects of propranolol 120 mg/day and 240 mg/day were no...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hypertension
سال: 2002
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(02)02939-4